What is OxiWear?
OxiWear specializes in the development of advanced wearable technology designed to provide continuous, real-time monitoring of vital health metrics, specifically blood oxygen saturation. By utilizing an ear-mounted form factor, the company offers a non-intrusive solution for individuals prone to sudden physiological changes. The core value proposition lies in its automated emergency alert system, which triggers notifications to emergency personnel when oxygen levels fall below critical thresholds. This functionality is essential for patients with chronic respiratory conditions, sleep disorders, or cardiac issues who may be unable to self-advocate during a medical crisis. By automating the detection and response process, OxiWear effectively mitigates the risks associated with sudden health deterioration, positioning itself as a vital safety net in the digital health landscape.
How much funding has OxiWear raised?
OxiWear has raised a total of $1.3M across 1 funding round:
Other Financing Round
$1.3M
Other Financing Round (2021): $1.3M with participation from Hourglass Venture Partners, Gaingels, Future Communities Capital, and CIT GAP Funds
Key Investors in OxiWear
Hourglass Venture Partners
Hourglass Venture Partners is an early-stage B2B venture capital fund that focuses on SaaS startups, providing agile product development and go-to-market support to high-growth businesses.
Gaingels
Gaingels is a leading investment syndicate representing the LGBTQ community and allies, investing in high-growth companies across various sectors including healthcare and technology.
CIT GAP Funds
Virginia Venture Partners is a program under the Virginia Innovation Partnership Corporation that focuses on investing in technology and life sciences startups to foster economic growth.
What's next for OxiWear?
With the recent influx of capital, OxiWear is poised to accelerate its product development roadmap and expand its reach within the healthcare market. The company's strategic focus will likely shift toward enhancing the sensitivity of its monitoring algorithms and integrating its alert system with broader telehealth platforms. As the firm transitions from its current development phase toward broader commercialization, the focus will remain on establishing partnerships with healthcare providers and insurance entities to integrate OxiWear into standard patient care protocols. This strategic expansion is expected to solidify the company's role as a leader in proactive, automated health monitoring, ultimately driving long-term value for stakeholders and improving patient outcomes.
See full OxiWear company page
